?Rare cancers? are uncommon malignant tumors, often defined as cancers with an annual incidence of less than 6 cases per 100,000 persons. Although individually rare, in total, rare cancers are estimated to represent more than 20% of all new cancer cases. The management of patients with rare cancers is particularly challenging because late or incorrect diagnosis is common and their rarity impedes clinical research, leading to substantial uncertainty regarding optimal treatment strategies. The decision-making process for rare cancer treatment management is complex and challenging because it requires balancing the clinical benefit of a treatment regimen with life expectancy, patient values, treatment goals, comorbidities, and potential treatment-related adverse events in a setting of limited research evidence.

Agency
National Institute of Health (NIH)
Type
Resource and Support Contracts (N02)
Project #
261201300395P-0-0-1
Application #
8761311
Study Section
Project Start
2013-09-18
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$74,592
Indirect Cost
Name
Brown University
Department
Type
DUNS #
001785542
City
Providence
State
RI
Country
United States
Zip Code
02912